Company / Gross Margin
Integra Lifesciences Holdings Gross Margin History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
62.0%
FY2020
5-year range
-
FY2016-FY2020
Trend
-1.2%
vs FY2019
Sector context
#39 of 96
Health Care
What the data says
At 62.0%, Integra Lifesciences Holdings's gross margin ranks #39 of 96 in the Health Care sector. Gross Margin has fluctuated over the past 5 years, ranging from 61.2% in FY2018 to 72.8% in FY2017.
Based on SEC 10-K filings.
62.0% in FY2020 with a 3-year CAGR of -10.8%.
Remained stable around 62.0% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -10.8pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#39 of 96 in Health CareTop 41% of 96This company 62.0% Sector average 53.6%
▼
+15.8% above sector average
Key checks
Key Insights
- In FY2020, gross margin decreased 1.2% year-over-year.
- Currently 8.4pp above the Health Care sector average.
- Peak gross margin was recorded in FY2017.
- Lowest gross margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | 62.0% | -1.2% |
| FY2019 | 62.8% | +2.6% |
| FY2018 | 61.2% | -16.0% |
| FY2017 | 72.8% | +4.3% |
| FY2016 | 69.8% | +10.8% |
As of FY2020 · SEC 10-K · Updated Jun 30, 2026